Robert Lustig, MD: AMP Kinase is a Master Regulator & the Role of Metformin
Short excerpt from a talk by Robert Lustig, MD, asserting that AMP kinase (AMPK) is a master regulator of metabolic pathways. Lustig claims activating AMPK promotes beneficial processes and inhibits harmful ones; he links metformin’s use in type 2 diabetes and ongoing trials (led by Nir Barzilai at Albert Einstein) exploring metformin as a longevity-promoting agent via AMPK activation and improved mitochondrial function.
Chapters
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet